VELTIN
LOE ApproachingNDATOPICALGEL
Approved
Jul 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
VELTIN by Almirall is clindamycin: [see microbiology (). First approved in 2010.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VELTIN is a topical gel combination of clindamycin and tretinoin approved for acne treatment. Clindamycin provides antimicrobial activity while tretinoin reduces comedone formation and increases epithelial cell turnover. The fixed-dose combination targets inflammatory and comedonal acne through dual mechanism action.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting defensive positioning and optimization-focused team priorities.
Mechanism of Action
Clindamycin: [See Microbiology ().] Tretinoin: Although the exact mode of action of tretinoin is unknown, current evidence suggests that topical tretinoin decreases cohesiveness of folliculare epithelial cells with decreased microcomedone formation. Additionally, tretinoin stimulates mitotic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VELTIN offers experience in defensive portfolio management and LOE strategy within a mature dermatology franchise. Career growth potential is moderate; roles emphasize market retention, competitive positioning, and transition planning rather than expansion.
Brand Manager
Worked on VELTIN at Almirall? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.